GSK Awarded Up to $200 Million by U.S. Government to Develop New Antibiotics
Friday, May 24, 2013
Funding will support development of drugs to fight antibiotic resistance and bioterrorism.
EMD Millipore and PharmaCell Announces Collaboration
Friday, May 24, 2013
Collaboration to evaluate EMD Millipore’s Mobius® bioreactor platform for expansion of HepaRG® cells.
WIL Research Partners with Three S Japan
Friday, May 24, 2013
Partnership to expand full portfolio of global safety assessment services to the Japanese market.
Merck Provides Update on Phase III Clinical Program for Preladenant
Friday, May 24, 2013
Merck provided an update on the clinical program for preladenant, Merck’s investigational adenosine A2A receptor antagonist for the treatment of Parkinson’s disease (PD).
Celgene Announces U.S. FDA Grants Priority Review for ABRAXANE® sNDA
Friday, May 24, 2013
European Medicines Agency accepts regulatory submission of Type II variation for ABRAXANE for the treatment of advanced pancreatic cancer.
Common Childhood Asthma Not Rooted in Allergens, Inflammation
Friday, May 24, 2013
Discovery of origins of a unique form of asthma may lead to a precision medicine approach to treatment.
Looking for the Telltale Gene
Friday, May 24, 2013
A new genetic test allows parents to peer into their unborn children's medical future.
AB SCIEX Improves Food Safety with New Method to Identify Markers for Horse Meat
Friday, May 24, 2013
New LC/MS/MS-based meat speciation method detects numerous animal protein markers in a single analysis with higher accuracy and reliability than existing methods.
Multiple Research Teams Unable to Confirm High-Profile Alzheimer’s Study
Friday, May 24, 2013
Teams of highly respected Alzheimer’s researchers failed to replicate what appeared to be breakthrough results for the treatment of this brain disease when they were published last year in the journal Science.
|
|
|
| << | 1 2 3 4 5 6 7 | >> | | Showing Results 1 - 10 of 22337 |
|
|
